Tech Company Financing Transactions
Imbed Biosciences Funding Round
On 11/6/2019, Imbed Biosciences raised $4 million in Series A funding from Formidable Asset Management, private investors and WISC Partners.
Transaction Overview
Company Name
Announced On
11/6/2019
Transaction Type
Venture Equity
Amount
$4,000,000
Round
Series A
Investors
Formidable Asset Management (Lead Investor)
Proceeds Purpose
The funding will be used to commercialize the company's FDA-cleared Microlyte Matrix wound dressing indicated for the management of chronic ulcers, burns, and surgical wounds.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
5520 Nobel Dr. 100
Fitchburg, WI 53711
USA
Fitchburg, WI 53711
USA
Phone
Website
Email Address
Overview
Imbed's vision is to develop next-generation medical devices that can reduce patient pain and costs for management of burns, chronic wounds, hernia meshes, gastro-intestinal defects, and dural membranes.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Ankit Agarwal
Co-Founder
Nicholas Abbott
Co-Founder
Charles Czuprynski
Co-Founder
Jonathan McAnulty
Co-Founder
Christopher Murphy
Co-Founder
Michael Schurr
VP - Bus. Development
Gary Robinson
VP - Product Management
Jeffrey Dalsin
VP - R & D
Gaurav Pranami
Browse more venture capital transactions:
Prev: 11/6/2019: Arweave venture capital transaction
Next: 11/6/2019: Shape Therapeutics venture capital transaction
Share this article
Where The Data Comes From
We do our best to record funding rounds that are announced publicly. VC investment data records reported here are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs